Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Rubius Therapeutics stock (RUBY)

Buy Rubius Therapeutics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Rubius Therapeutics is a biotechnology business based in the US. Rubius Therapeutics shares (RUBY) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.06 – the same closing value as a week prior. Rubius Therapeutics employs 6 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Rubius Therapeutics stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • Complimentary access to a financial planner and automated investing

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Rubius Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – RUBY. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Rubius Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a no-advisory-fee robo-advisor and complimentary access to financial planners.
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
eToro
Finder Score: 4 / 5: ★★★★★
EXCLUSIVE
eToro
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.9%
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
No commission stock, ETF and options trades, with 4.9% interest on your options account balance and no options contract fees.
Robinhood
Finder Score: 4.4 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Rubius Therapeutics stock price (PINK: RUBY)

Use our graph to track the performance of RUBY stocks over time.

Rubius Therapeutics shares at a glance

Information last updated 2024-02-08.
Latest market close$0.06
52-week range$0.02 - $0.06
50-day moving average $0.02
200-day moving average $0.02
Wall St. target price$1.00
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-1.99

Rubius Therapeutics price performance over time

Historical closes compared with the close of $0.057 from 2023-12-29

1 week (2024-09-29) N/A
1 month (2024-09-06) N/A
3 months (2024-07-06) N/A
6 months (2024-04-06) N/A
1 year (2023-10-10) 243.37%
2 years (2022-10-10) -85.86%
3 years (2021-10-08) 15.96
5 years (2019-10-10) 8.425

Rubius Therapeutics financials

Gross profit TTM $0
Return on assets TTM -46.63%
Return on equity TTM -185.31%
Profit margin 0%
Book value $0.17
Market Capitalization $5.2 million

TTM: trailing 12 months

Rubius Therapeutics share dividends

We're not expecting Rubius Therapeutics to pay a dividend over the next 12 months.

Rubius Therapeutics share price volatility

Over the last 12 months, Rubius Therapeutics's shares have ranged in value from as little as $0.0166 up to $0.057. A popular way to gauge a stock's volatility is its "beta".

RUBY.US volatility(beta: 2.21)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Rubius Therapeutics's is 2.208. This would suggest that Rubius Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Rubius Therapeutics overview

Rubius Therapeutics, Inc. , a biopharmaceutical company, focuses on the development of red cell therapeutics for the treatment of cancer and autoimmune diseases. The company was formerly known as VL26, Inc and as changed its name to Rubius Therapeutics, Inc. in 2015. Rubius Therapeutics, Inc. was incorporated in 2013 and is based in Foxborough, Massachusetts. .

Frequently asked questions

What percentage of Rubius Therapeutics is owned by insiders or institutions?
Currently 5.498% of Rubius Therapeutics shares are held by insiders and 0.386% by institutions.
How many people work for Rubius Therapeutics?
Latest data suggests 6 work at Rubius Therapeutics.
When does the fiscal year end for Rubius Therapeutics?
Rubius Therapeutics's fiscal year ends in December.
Where is Rubius Therapeutics based?
Rubius Therapeutics's address is: 399 Binney Street, Cambridge, MA, United States, 02139
What is Rubius Therapeutics's ISIN number?
Rubius Therapeutics's international securities identification number is: US78116T1034
What is Rubius Therapeutics's CUSIP number?
Rubius Therapeutics's Committee on Uniform Securities Identification Procedures number is: 78116T103

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site